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Abstract: Rho kinase (ROCK) is a well-known downstream effector of Rho and plays an 
important role in various physiopathological processes. In this study, we aim to investigate 
the correlation between ROCK and microvascular damage in rat brain subjected to middle 
cerebral  artery  occlusion  (MCAO)  and  reperfusion,  and  to  elucidate  the  mechanisms 
underlying  the  microvascular  damage.  ROCK  and  matrix  metalloproteinase  9  (MMP9) 
mRNA levels were determined by real time quantitative PCR, Laminin was detected by 
immunofluorescence and Blood Brain Barrier (BBB) permeability was examined by Evans 
Blue  (EB)  in  rat  MCAO  models.  We  observed  similar  patterns  of  changes  in  ROCK 
expression, brain EB content, and Laminin expression at different time points after brain 
ischemia. Statistical analysis further confirmed a significant linear correlation of ROCK 
expression  with  the  onset  of  microvascular  damage  in  brain.  Furthermore,  the  ROCK 
inhibitor  fasudil  decreased  brain  EB  content  but  increased  Laminin  expression.  These 
results provide strong evidence that ROCK mediates microvascular damage. In addition, 
we found that fasudil could significantly inhibit MMP9 expression induced by ischemia. 
Thus, our findings suggest that ROCK promotes microvascular damage by upregulating 
MMP9 and reveal ROCK as a promising therapeutic target for stroke. 
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1. Introduction 
Approximately 700,000 individuals are afflicted with a stroke each year in the United States and 
currently approximately two million survivors of stroke live in the U.S. with prolonged disability. In 
China, 1.5 million people die from stroke each year and in developed countries stroke is the third 
leading cause of death, only surpassed by heart disease and cancer [1]. The economic, social and 
psychological costs of stroke are so significant that intense research has focused on understanding the 
underlying pathophysiology of stroke and the development of effective therapeutic options. 
Therapies that reinstate cerebral blood flow (CBF) to the ischemic territory are partially efficacious 
but  may  lead  to  disability  due  to  lack  of  neurovascular  unit  protection  and  the  resulting  brain 
microvascular damage after reperfusion. Microvascular damage, in turn, results in the accumulation of 
neutrophils,  the  activation  of  leukocytes  and  the  release  of  inflammatory  cytokines,  which  then 
promote  a  cellular inflammatory  response and form a  positive  feedback.  Consequently, release of 
oxidants,  proteolytic  enzymes  and  inflammatory  cytokines  change  the  blood  brain  barrier  (BBB) 
permeability properties, leading to brain edema formation. Remarkably, matrix metalloproteinases (MMPs) 
released by activated leukocytes affect the integrity of the neurovascular unit, degrading the basal 
membrane [2]. In particular, MMP9 has been known to contribute to hemorrhages after stroke and 
thrombolysis by t-PA treatment [3]. Moreover, MMP9 knockout mice did not display BBB disruption 
after  transient  ischemia  [4].  These  results  suggest  that  MMP9  plays  an  important  role  in  BBB 
disruption after stroke and indicate MMP9 as a promising therapeutic target for stroke. 
Rho kinase (ROCK), a downstream effector of Rho, is a serine/threonine kinase that is activated 
when  bound  to  the  active  GTP-bound  form  of  Rho.  Recent  studies  demonstrated  that  ROCK  is 
activated in cerebral ischemia and ROCK inhibitors reduce infarct size in focal cerebral ischemia [5]. 
However, the molecular details of the contribution of ROCK to brain microvascular damage remain 
largely elusive. Therefore, in this study, we investigated the relationship between ROCK expression and 
microvascular damage in rat brain subjected to middle cerebral artery occlusion and reperfusion (MCAO). 
We further examined the effect of ROCK inhibitor on microvascular damage and MMP9 expression to 
elucidate the mechanisms underlying the microvascular damage. Our results established a correlation 
among  ROCK,  brain  EB  content,  laminin  expression  and  MMP9  expression  following  MCAO, 
demonstrating the protective effects of fasudil on microvascular damage during cerebral ischemia. 
2. Materials and Methods 
2.1. Experimental Animals and MCAO Model 
Adult male Sprague-Dawley rats (300 ±  30 g) were cared for according to the Guide for the Care 
and Use of Laboratory Animals. The committee for experimental animals of Second Military Medical 
University approved all surgical  procedures.  Rats  were anesthetized  with  chloral  hydrate (350 mg/kg 
intraperitoneally;  IP)  and  subjected  to  MCAO  as  described  previously  [6].  In  brief,  we  exposed  Int. J. Mol. Sci.2011, 12                     
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the  right  common  carotid  artery,  internal  carotid  artery,  and  external  carotid  artery  surgically.  A  
4–0 monofilament nylon suture (Beijing Sunbio Biotech Co. Ltd.) with a rounded tip was inserted into 
the internal carotid artery through the external carotid artery stump and gently advanced to occlude the 
MCA. After 60 min of MCAO, the suture was removed to restore blood flow (reperfusion confirmed 
by laser Doppler). Sham-operated rats were manipulated in the same  way; the monofilament was 
inserted  to  a  depth  of  1.0–2.0  mm  with  the  MCA  not  occluded.  Core  body  temperatures  were 
monitored  with  a  rectal  probe  and  maintained  at  37  ° C  during  the  whole  procedure.  All  surgical 
procedures were performed under an operating stereomicroscope. 
In one set, 120 rats were randomly divided into sham group, reperfusion 6 h group, reperfusion 24 h 
group, reperfusion 48 h group, and reperfusion 72 h group (24 rats per group). In another set, 72 rats 
were randomly divided into sham group, reperfusion 24 h group, and ROCK inhibitor (fasudil) treated 
group (24 rats per group) and were IP administered with saline or fasudil (15 mg/kg) once before 
operation and once 12 h after operation.  
2.2. Ischemic Core and Penumbra Dissections 
The ischemic core and penumbra of the cortex were dissected following the protocols described 
previously [7]. Briefly, each hemisphere was cut longitudinally, from dorsal to ventral at 1.5 mm from 
the midline to exclude medial brain structures that were supplied primarily by the anterior cerebral 
artery. A transverse diagonal incision at approximately the “2 o’clock” position separated the core 
from the penumbra. 
2.3. Determination of BBB Permeability 
Evans Blue (EB, 2% in saline, 4 mL/kg) was injected intravenously 24 h after the onset of MCAO. 
The chest was subsequently opened under halothane anesthesia 1 h later. Rats were perfused with 
saline through the left ventricle at 110 mm Hg pressure until colorless perfusion fluid was obtained 
from the right atrium. After decapitation, the brain was blocked into 2 segments that included the 
levels bregma +2.7 and −0.3 mm. Coronal blocks were next divided into right and left hemispheres for 
local measurement of EB dye. Samples were weighed and placed in 50% trichloroacetic acid solution. 
Following homogenization and centrifugation, the extracted dye was diluted with ethanol (1:3), and its 
fluorescence was determined at 620 nm. Calculations were based on external standards in the same 
solvent  (100–500  ng/mL).  The  tissue  content  of  EB  was  quantified  from  a  linear  standard  curve 
derived from known amounts of the dye and was expressed per gram of tissue. 
2.4. Immunofluorescence Staining for Laminin 
For tissue harvesting, the rats were anesthetized with a lethal dose of sodium pentobarbital (80 mg/kg 
body  weight).  After  decapitation,  the  brain  was  washed  in  20%  phosphate-buffered  sucrose,  then 
embedded and mounted in Tissue-Tek OCT compound. Serial longitudinal frozen sections (4 μm) 
were cut, fixed, and washed with phosphate-buffered saline (PBS) for 5 min, 3 times. After incubation with 
5% normal goat serum for 1 h at RT, the sections were incubated with Laminin primary antibody (rabbit 
anti  rat,  Abcam)  in  a  humid  chamber  at  32  ° C  for  1  h.  The  immunoreaction  was  visualized  by 
treatment with CY3-conjugated goat anti-rabbit secondary antibody (Jackson) at 32 ° C for 30 min in Int. J. Mol. Sci.2011, 12                     
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the  dark.  Immunostained  sections  were  mounted  and  analyzed  using  a  Leica  epifluorescence 
microscope (Leica Microsystems Wetzlar GmbH, Germany). Three fields were randomly selected and 
semi-quantitation  of  the  positive  staining  was  performed  using  Leica-Qwin  software  with  the 
florescence value calculated as Ga (positive gray value)–GA (background gray value). 
2.5. RNA Isolation and Real-Time Quantitative PCR  
Total RNA was isolated from right cortical samples by Trizol reagent (Invitrogen), and RT was 
performed with TOYOBO RT kit (TOYOBO) according to the manufacturer’s instructions. PCR was 
performed with primers for ROCK (forward: 5’-CTGCTGAAGTCGTGCTTGCA-3’;  
Reverse: 5’-AGCATGTTATCGGGCTTCACA-3’, amplicon: 79 bp); 
MMP9 (forward: 5’-ACGAGGACTCCCCTCTGCAT-3’; 
Reverse: 5’-AGGCCTTGGGTCAGGTTTAGA-3’, amplicon: 83 bp); 
GAPDH was used as an internal standard (forward: 5’-CAGTGCCAGCCTCGTCTCAT-3’; 
Reverse: 5’-TGGTAACCAGGCGTCCGATA-3’, amplicon: 79 bp). 
The PCR products were quantified by ABI Prism
® 7900HT Sequence Detection System. 
2.6. Statistical Analyses 
All data are expressed as - x ±  s. All data were analyzed with SPSS11.0 statistical software. One-way 
ANOVA, Bonferroni, Kruskal-Wallis H test and Pearson correlated analysis were performed. P < 0.05 
was considered as statistically significant. 
3. Results 
3.1. Expression of ROCK at Different Time Points after MCAO 
By real-time quantitative PCR, we observed the changes of mRNA level of ROCK at different time 
points after MCAO (Table 1). The expression level of ROCK increased 6 h after reperfusion and the 
increase  was  significant  compared  with  a  sham  group  (P  <  0.01).  The  expression  of  ROCK  
kept  increasing  6–24  h  after  reperfusion,  and  then  decreased  gradually  48  h  after  perfusion.  The 
different time points group all showed significant difference in ROCK expression compared with the 
sham group (P < 0.01), while there was no significant difference between 24 h after reperfusion group 
and 6 h after reperfusion group (P > 0.05). 
3.2. BBB Permeability at Different Time Points after MCAO 
By EB method, we measured EB contents at different time points after MCAO (Table 1). Clearly, EB 
content increased 6 h after perfusion, with significant difference from sham group (P < 0.01). EB 
content  gradually  increased  6–48  h  after  perfusion,  suggesting  that  BBB  permeability  increased 
gradually and microvascular structure was gradually damaged. However, EB content began to decrease 
48 h after perfusion. The difference in EB content was significant when each individual group was 
compared with sham group (P < 0.01) or compared with each other (P < 0.01). Int. J. Mol. Sci.2011, 12                     
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Table  1.  The  mRNA  level  of  ROCK,  brain  Evans  Blue  (EB)  content,  and  
semi-quantitation of Laminin expression following middle cerebral artery occlusion (MCAO). 
Group  n  ROCK mRNA  EB content (μg/g)  Laminin expression 
sham  5  0.466 ±  0. 030  0.202 ±  0.019  168.91 ±  6.73 
ischemia reperfusion         
reperfusion 6 h  5  0.617 ±  0.017 *  1.372 ±  0.123 *  149.45 ±  4.38 * 
reperfusion 24 h  5  0.662 ±  0.016 *  3.764 ±  0.160 *  115.56 ±  8.29 * 
reperfusion 48 h  5  0.838 ±  0.036 *  4.650 ±  0.286 *  82.95 ±  12.33 * 
reperfusion 72 h  5  0.713 ±  0.018 *  2.982 ±  0.163 *  124.34 ±  5.29 * 
* P < 0.01 vs. sham group. 
3.3. Expression of Laminin at Different Time Points after MCAO 
By immunofluorescence staining, we detected the expression of Laminin in the microvascular basal 
membrane in rat ischemic penumbra. As shown in Figure 1, we observed different staining patterns for 
Laminin at different time points after MCAO. While strong positive staining for Laminin was detected 
in the sham group, slightly weaker staining was observed 6 h after perfusion. Moreover, 24 h after 
perfusion, the staining for Laminin was significantly weaker with both the positive areas and the 
staining intensity decreased. We could also observe basal membrane damage such as breakdown. The 
weakest staining for Laminin was observed at 48 h after perfusion, when both the positive areas and 
staining intensity were lowest. The staining was blurry and the shape was irregular, demonstrating that 
substantial basal membrane damage occurred. In comparison, the staining for Laminin was recovered 
and microvascular regeneration could be observed 72 h after perfusion. 
To  obtain  a  quantitative  comparison  of  Laminin  expression,  we  performed  semi-quantitative 
analysis with Leica-Qwin software. The results demonstrated that Laminin expression decreased gradually 
6–48 h after perfusion, was lowest at 48 h after perfusion, and then gradually increased (Table 1). At 
the different time points, all groups showed significant difference in Laminin expression compared 
with the sham group (P < 0.01). In addition, although there was no significant difference between the 
24 h after reperfusion group and 72 h after reperfusion group (P > 0.05), there was a significant 
difference when any other two groups were compared (P < 0.05). 
3.4. Correlation among ROCK mRNA Level, Brain EB Content and Laminin Expression after MCAO 
Since  we  observed  similar  changes  in  ROCK  mRNA  level,  brain  EB  content  and  Laminin 
expression after MCAO, next we attempted to address their association. Based on statistical analysis, 
the correlation coefficient r between ROCK expression and brain EB content was 0.925，and it was 
statistically significant (P = 0.025 < 0.05). The correlation coefficient r between ROCK expression and 
Laminin expression was −0.955，and it was also statistically significant (P = 0.011 < 0.05). Thus, these 
data suggest that ROCK expression is positively correlated with BBB permeability and negatively 
correlated with Laminin expression. Int. J. Mol. Sci.2011, 12                     
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Figure 1. Immunofluorescence staining for Laminin at basal membrane in rat ischemic 
penumbra.  Laminin expression was  observed using aLeica  epifluorescence  microscope. 
The red signal represents positive staining. (A) sham; (B) reperfusion 6 h; (C) reperfusion 
24 h; (D) reperfusion 48 h; (E) reperfusion 72 h. Amplification: 40× . 
 
3.5. ROCK Inhibitor Decreases BBB Permeability after MCAO 
Since ROCK plays a role in the pathology of stroke, we decided to use the ROCK inhibitor fasudil 
to evaluate its effects on microvascular damage after MCAO. First, we examined the impact of fasudil 
on BBB permeability by measuring brain EB content. As shown in Table 2, compared with the sham 
group,  brain  EB  content  was  significantly  higher  in  both  the  24  h  reperfusion  group  and  24  h 
reperfusion plus fasudil group (P < 0.05). However, brain EB content was significantly lower in the  
24 h reperfusion plus fasudil group than in the 24 h reperfusion group (P < 0.05), suggesting that the 
ROCK inhibitor decreases BBB permeability. 
Table  2.  The  mRNA  level  of  MMP9,  brain  Evans  Blue  (EB)  content,  and  semi-
quantitation of Laminin expression following middle cerebral artery occlusion (MCAO) 
and fasudil treatment. 
Group 
EB content (mg/g) 
(n = 5) 
Laminin expression 
(n = 5) 
MMP9 mRNA 
(n = 10) 
sham  0.210 ±  0.039  167.89 ±  8.97  0.514 ±  0.055 
MCAO  3.376 ±  0. 134
 *  109.72 ± 12.01
 *  0.762 ± 0.021
 * 
Fasudil  1.930 ± 0.079
 *
,†  142.02 ± 4.82
 *
,†  0.659 ± 0.028
 *
,† 
* P < 0.05 vs. sham group; 
† P < 0.05 vs. MCAO group. 
3.6. ROCK Inhibitor Rescues Laminin Expression after MCAO 
Next we examined the effect of fasudil on basal membrane by immunofluorescence staining for 
Laminin. As shown in Figure 2, compared with the sham group, 24 h after perfusion, the staining for 
A  B 
D  E 
C Int. J. Mol. Sci.2011, 12                     
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Laminin  was  much  weaker  and  basal  membrane  breakdown  was  obvious.  Interestingly,  fasudil 
partially rescued  positive staining for Laminin and promoted microvascular regeneration. 
Further semi-quantitative analysis demonstrated that Laminin expression was significantly lower in both 
the  24  h  reperfusion  group  and  24  h  reperfusion  plus  fasudil  group  compared  with  the  sham  
group (P < 0.05). Nevertheless, Laminin expression was significantly higher in the 24 h reperfusion 
plus fasudil group compared with the 24 h reperfusion group (P < 0.05) (Table 2). Collectively, these 
data suggest that the ROCK inhibitor could antagonize basal lamina damage and the downregulation of 
Laminin following brain ischemia reperfusion. 
Figure 2. Immunofluorescence staining for Laminin at basal membrane in rat ischemic 
penumbra. Laminin expression was observed using a Leica epifluorescence microscope. 
The red signal represents positive staining. (A) sham; (B) reperfusion 24 h; (C) reperfusion 
24 h + fasudil. Amplification: 40 × . 
 
3.7. ROCK Inhibitor Inhibits MMP9 Expression after MCAO 
Finally, we examined the effect of fasudil on MMP9 expression after MCAO. Real-time quantitative 
PCR  experiments  demonstrated  that  the  mRNA  level  of  MMP9  was  significantly  higher  in  both  
the 24 h reperfusion group and the 24 h reperfusion plus fasudil group, compared with  the sham  
group (P < 0.05). However, the mRNA level of MMP9 was significantly lower in the 24 h reperfusion 
plus fasudil group compared with 24 h reperfusion group (P < 0.05) (Table 2). Thus, these results 
indicate that ROCK inhibitor inhibits MMP9 expression following brain ischemia reperfusion. 
4. Discussion 
Cerebral microvessels have a unique feature, which protects sensitive brain cells from disturbing 
elements circulating in the blood. The BBB exists primarily as a selective diffusion barrier at the level 
of the cerebral microvascular endothelium, characterized by the presence of tight cell-cell junctions 
and a lack of fenestrations. Pericytes and endothelial cells are ensheathed by the basal membrane, a 30 
to  40  nm  thick  membrane.  The  basal  membrane  is  one  of  the  three  basic  components  in  the 
microvasculature and its main component is Laminin. Accumulating evidence indicates that Laminin 
dysfunction leads to basal membrane damage, microvascular impairment and BBB defects, which in 
turn  results  in  brain  edema  and  hemorrhage  transformation  after  perfusion.  It  has  been  reported 
recently that Laminin expression was downregulated during ischemia-reperfusion [8]. Thus, Laminin 
level may reflect the integrity of basal membrane and indicate possible microvascular damages.  
A  B  C Int. J. Mol. Sci.2011, 12                     
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ROCK  is  a  well-known  downstream  effector  of  Rho  and  plays  an  important  role  in  various 
physiopathological  processes.  For  example,  ROCK  is  implicated  in  vascular  smooth  muscle  cell 
contraction, actin cytoskeleton organization, cell adhesion and motility, and gene expression. At the 
molecular  level,  ROCK  activates  signaling  cascades  that  accelerate  inflammation/oxidative  stress, 
thrombus formation, and fibrosis, thus contributing to microvascular damage. 
Recently, the ROCK inhibitor fasudil was reported to protect the vascular endothelium by inhibiting 
neutrophil adhesion and reducing neutrophil-induced endothelial injury, indicating the critical role of 
the Rho/ROCK pathway in diabetic retinal microvasculopathy [9]. In the present study, we found 
similar pattern of changes in ROCK expression, brain EB content that indicates BBB permeability, and 
Laminin expression at different time points after brain ischemia reperfusion. Statistical analysis further 
confirmed the correlation among ROCK mRNA level, brain EB content and Laminin expression as we 
documented.  These  results  strongly  suggest  that  ROCK  is  involved  in  microvascular  damage. 
Furthermore, by use of the ROCK inhibitor fasudil, we found that fasudil decreased brain EB content 
but increased Laminin expression, thus exhibiting protective effects against microvascular damage. 
These results provide further evidence that ROCK mediates microvascular damage.  
Matrix metalloproteinases (MMPs) play important roles in the pathogenesis of CNS diseases that 
share common pathophysiological processes, such as BBB disruption, oxidative stress, remodeling of 
the extracellular matrix (ECM) and inflammation [10]. The expression of MMPs, especially MMP2, 
MMP9  and  MMP10,  is  induced  by  cerebral  ischemia  [11].  Among  MMPs,  MMP9  is  crucially 
involved in BBB disruption due to the degradation of the ECM and damage of basal lamina, which 
consequently  leads  to  brain  edema  and  hemorrhage  [12–14].  Most  recently,  MMP9  was  found  to 
promote  hemorrhagic  transformation  and  spontaneous  intracerebral  hemorrhage  during 
hypertension [15]. MMP9 is also involved in the pathogenesis of early brain injury of subarachnoid 
hemorrhage through degrading Laminin [16]. In accordance with these reported studies, here we found 
that MMP9 expression was increased significantly in the rat ischemic penumbra 24 h after reperfusion, 
thus confirming the induction of MMP9 by brain ischemia. Interestingly, we found that fasudil could 
significantly  inhibit  MMP9  expression  induced  by  ischemia,  suggesting  that  ROCK  may  promote 
microvascular  damage  by  upregulating  MMP9  expression  during  ischemia  reperfusion.  However, 
further investigation of the potential mechanism by which ROCK regulates MMP9 during cerebral 
ischemia will be necessary to confirm our conclusion and will be the aim of our next study.  
In summary, to our knowledge, we are the first to establish the correlation among ROCK mRNA 
level, brain EB content and Laminin expression following MCAO. Our results provide strong evidence 
that ROCK mediates microvascular damage. In addition, by use of the ROCK inhibitor fasudil, our 
study suggests a novel mechanism by which ROCK may upregulate MMP9 expression to contribute to 
microvascular  damage  during  cerebral  ischemia.  Taken  together,  our  findings  reveal  ROCK  as  a 
promising therapeutic target for stroke.  
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